NantOmics explained

NantOmics is a biotechnology company based in Culver City, California, which provides molecular diagnostic products for personalized cancer treatment. It is part of the NantWorks network, a corporation consisting of different startups in the medical and health industry.^[1]

History

NantOmics was founded in 2013 by billionaire Patrick Soon-Shiong. In 2015 NantOmics bought the cancer diagnostics company OncoPlex Dx.^[2] In 2017 the company acquired the consumer genomics startup Genos.^[3] Three years later, in 2020, NantOmics shutdown Genos.^[4]

Products

GPS Cancer involves sequencing of the genome and RNA of tumor cells in comparison to normal cells from the same individual in order to develop personalized treatments.^[5] About 327,000 cancer patients participated in a GPS cancer pilot project in 2017.^[6]

References

1. Web site: NantOmics, LLC: Private Company Information - Bloomberg. www.bloomberg.com. 2018-03-30.
2. News: NantOmics Acquires OncoPlex Diagnostics, an Accredited Proteomics Diagnostic Laboratory. 2018-03-30. en.
3. Web site: Bio-IT World. www.bio-itworld.com. en-us. 2018-03-30.
4. Web site: NantOmics Shuts Down Genos Direct-to-Consumer Genomics Services . genomeweb.
5. Web site: GPS Cancer Overview. GPS Cancer. en-US. 2018-03-30.
6. News: NantHealth Reports 16% Increase in 2017 First Quarter Total Net Revenue; SaaS Revenue Rose 11% and GPS Adoption Continues to Climb. 2018-03-30. en.